An, Rui
Lin, Chunnan
Lu, Zeguang
Lin, Wenqian
Tan, Hongying
Zhang, Tianhua
Li, Huiting
Cao, Longhui
Article History
Received: 8 April 2024
Accepted: 4 April 2025
First Online: 28 April 2025
Declarations
:
: This prospective, randomized, double-blind clinical trial was approved by the Ethics Committee of Sun Yat-sen University Cancer Center (Number. B2021-031-01).
: All patients gave written informed consent before inclusion.
: Informed consent was obtained from all subjects and/or their legal guardian(s).
: The authors declare no competing interests.